Stock Information
BioMarin Pharmaceutical Inc (BMRN)
Ticker Symbol: BMRN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $11,859.22 mil
Piotroski score: 5
PE Ratio: 30.1962
EPS (TTM): 1.7631
Revenue (TTM): $16.76 M
Dividend Yield: N/A%
ROE: 5.82%
Latest News
-
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks
Fri, Mar 20, 2026 6:22 PM
-
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026
Fri, Mar 20, 2026 4:27 PM
-
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position
Fri, Mar 20, 2026 4:21 PM
-
Top 3 Health Care Stocks That Are Set To Fly In March
Fri, Mar 20, 2026 6:23 AM
-
How The BioMarin (BMRN) Story Is Shifting With Voxzogo Risks And The Amicus Deal
Thu, Mar 19, 2026 12:18 AM
-
BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO
Wed, Mar 18, 2026 11:39 AM
-
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally
Tue, Mar 17, 2026 12:20 AM
-
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally
Tue, Mar 17, 2026 12:13 AM
Key Financials
Financial data not available
